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INTRODUCTION 
The role of free radicals and active oxygen is becoming 
increasingly recognized in the pathogenesis of many 
human diseases, including cancer, aging and 
atherosclerosis1. Human body can be protected from these 
harmful compounds by enzymatic system, catalase, 
scavengers and antioxidants. Antioxidants are capable of 
preventing oxidative processes by inhibiting the initiation 
and propagation of an   oxidative chain reaction. They are 
important in the prevention   of   many   oxidative-stress 
related diseases2. Several studies have shown that the 
therapeutic effects of some medicinal plants, fruits and 
even vegetables which are commonly used in folklore 
remedies against many diseases can be attributed to the 
antioxidant properties of their phytoconstituents3, 4.  
 An extract of vine Ipomoea squamosa, a member of the 
Morning Glory genus, has been found to exhibitis strong 
cytotoxicity. After initial investigations by the then 
pharmaceutical partner Bristol-Myers Squibb, the extract 
was reinvestigated at Virginia Polytechnic Institute and 
State University and was found to contain a series of six 
resin glycosides named Ipomoeassins A-F with potent 
antiproliferative activities5. The compounds were 
biologically interesting because in spite of their very 
similar chemical structures, they had antiproliferative 
activities differing by about 2 orders of magnitude. This 
finding indicated that their antiproliferative activities were 
not due to some general detergent effect. A follow up 
experiment in the NCI 60-cell-line panel followed by a 
COMPARE analysis indicated a previously unknown 
mechanism of action. Ipomoeassin F and ipomoeassins B 
and E have been synthesized6, 7, 8. Ipomoea muricata, 
Ipomoea bahiensis and Ipomoea squmosa are from same 
genus show biological properties such as cardiac 
depresent, spasmolytic antimicrobial, anticancer, cytotoxic 
activity9, 10. 
 We have selected from the same genus the plant Ipomoea 
leari. The Plant belongs to, Family Convolculaceae, is 
twining perennial vine. This plant is famous as Blue Dawn 
and morning glory vine with a striking purple-blue color 
flowers. The flowers open in the morning and fade to 
magenta in the evening. The Origin of the plant is 
uncertain, but it is widespread throughout the tropical 
world and commonly found at hill stations of India like 
Ooty, Nainital and Mussoorie, scrambling over fences and 
over woody plants. Ethnopharmacological information 
available on the plant indicates that the root is used for 
dysentery, blood pressure and Waker carcinoma 256 in 
rat11. 
In view of this ethnopharmacological information on the 
plant, it was proposed screen Ipomoea leari successive 
extracts and its fraction(s) for the in vitro and in vivo 
antioxidant activity using standard procedures. 
MATERIALS AND METHODS 
Plant material 
The plant Ipomoea leari was purchased from Abirami 
Botanicals, Tuticorin, Tamilnadu, India, and authenticated 
by Dr. D. Suresh Baburaj, Survey of Medicinal Plants and 
Collection Unit, Ootacamund, India. A voucher specimen 
(TIFAC 21) has been deposited for further reference at 
J.S.S College of Pharmacy herbarium, Ootacamund, India. 
Chemicals 
2,2-Diphenyl-2-picryl hydrazyl (DPPH) and 2,2-
azinobis(3-ethylbenzo-thiazoline-6-
sulphonicacid)diammoniumsalt (ABTS) were obtained 
from Sigma–Aldrich Co., St. Louis, USA. Rutin and p -
nitroso dimethyl aniline (p -NDA) were obtained from 
Acros Organics, NJ, USA. Naphthyl ethylene diamine 
dihydrochloride (NEDD) was from Roch-Light Ltd., 
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Suffolk, UK, ascorbic acid, nitro blue tetrazolium (NBT) 
and butylatedhydroxyanisole (BHA) were from SD Fine 
Chemicals Ltd., Mumbai, India and 2-deoxy-d -ribose was 
from Hi-Media Laboratories Pvt. Ltd., Mumbai, India. 
Sodium nitroprusside and Silymarin were from Ranbaxy 
Laboratories Ltd., Mohali, India. Sulphanilic acid used was 
from E-Merck (India) Ltd., Mumbai, India. All chemicals 
used were of analytical grade. 
Animals 
Healthy male albino rats of wistar strain (180–220 g) were 
obtained from the animal house, J.S.S. College of 
Pharmacy, Ootacamund, India, and were maintained under 
standard environmental conditions (22–28ºC, 60–70% 
relative humidity, 12-h dark:12-h light cycle) and were fed 
with standard rat feed (M/S Hindustan Lever Ltd., 
Bangalore, India) and water ad libitum . The experiments 
were conducted as per the guidelines of CPCSEA, 
Chennai, India (approval no. JSSCP/IAEC/Ph.D/Phyto 
pharmacy/02/2010–2011). 
 Extraction procedure 
The plant was chopped to small pieces and dried in shade. 
The dried root was powdered and passed through sieve no. 
20 and extracted (600g) successively with 4.8 L each of n-
hexane (60–80ºC), chloroform, ethyl acetate and 
hydromethanolic (1:1) solvents in a Soxhlet extractor for 
18–20 h. The extracts were concentrated to dryness under 
reduced pressure and controlled temperature (40–50ºC). 
The n-hexane extract yielded an yellowish green sticky 
semisolid,(2.37g) The chloroform extract yielded green 
semisolid (6.07g). The ethyl acetate extract yielded dark 
blackish green solid (6.73g) and hydromethanolic extract 
yielded (21.54g), respectively. All the extracts were 
preserved in a refrigerator till further use. 
Isolation and fractionation 
The chloroform extract was concentrated and loaded in a 
column after adsorbing silica gel 60-120 mesh for 
isolation. About 35 different fractions were collected with 
different solvent system ranging from low to high polarity 
by gradient technique. Among all the fractions, the fraction 
showing good in vitro antioxidant (ILCF-28) was chosen 
for further studies. Repeated re-column chromatography of 
ILCF-28 yielded a colourless crystalline compound. This 
was characterized by melting point, IR, NMR and mass 
spectrum. 
Preparation of test and standard solutions 
All the four extracts of Ipomoea leari, fraction ILCF-28 
and the standard antioxidants (ascorbic acid, rutin and 
butylated hydroxy anisole) were dissolved in distilled 
dimethyl sulphoxide (DMSO) separately and used for the 
in vitro antioxidant assays using five different methods 
except the hydrogen peroxide method. For the hydrogen 
peroxide method (where DMSO interferes with the 
method), the extracts and the standards were dissolved in 
distilled methanol and used. The stock solutions were 
serially diluted with the respective solvents to obtain lower 
dilutions. A suspension of ILC, ILCF-28 and standard drug 
silymarin were prepared in sodium CMC (0.5%, w/v) 
using distilled water and used for in vivo experiments. 
Estimation of total phenolic content 
The amount of phenolic compounds in all the four extracts 
was estimated by using Folin–Ciocalteu reagent12. In a test 
tube, 0.4mL of the extract in methanol was taken, mixed 
with 2 mL of Folin–Ciocalteu reagent and 1.6mL of 
sodium carbonate. After shaking, it was kept for 2h and the 
absorbance was measured at 750 nm using a Shimadzu-
UV-160 spectrophotometer. Using gallic acid 
monohydrate, a standard curve was prepared. The linearity 
obtained was in the range of 1–10 g/mL. Using the 
standard curve, the total phenolic compounds content was 
calculated and expressed as gallic acid equivalent in mg/g 
of the extracts. 
 Estimation of Total flavonoid content  
Aluminum chloride colorimetric method was used for the 
estimation of flavonoids13.  The sample (1mL) was mixed 
with 3 mL of methanol, 0.2 mL of 10% aluminum 
chloride, 0.2 mL of 1 M potassium acetate and 5.6 mL of 
distilled water. The mixture was kept at room temperature 
for 30 minutes and the absorbance of the reaction mixture 
was measured at 415 nm a with PerkinElmer UV/Visible 
spectrophotometer. A calibration curve was prepared by 
preparing quercetin solutions at 20, 40, 60, 80 and 100 
µg/mL concentrations in methanol. The concentration of 
flavonoid was found using the standard curve and the 
results were expressed as mg of quercetin equivalents (QE) 
per g dry weight (mg QE/g DW) of the sample. 
In vitro antioxidant activity 
The four extracts and the fraction ILCF-28 were tested for 
their in vitro antioxidant activity using standard methods. 
In all these methods, a particular concentration of the 
extract or standard solution was used which gave a ﬁnal 
concentration of 1000–0.45 g/mL after all the reagents 
were added. Absorbance was measured against a blank 
solution containing the extract or standard, but without the 
reagents. A control test was performed without the extracts 
or standards. Percentage scavenging and IC50 values ± 
S.E.M. (IC50 value is the concentration of the sample 
required to inhibit 50% of radical) were calculated. 
DPPH radical scavenging method 
A 10µL aliquot of the extracts, or the standards was added 
to 200 µL of DPPH in methanol solution (100 µM) in a 
96-well microtitre plate (Tarson Products (P) Ltd., 
Kolkota, India). After incubation at 37ºC for 20 min, the 
absorbance of each solution was determined at 490 nm 
using ELISA reader (Bio-Rad Laboratories Inc., CA, USA, 
Model 550)14. 
Nitric oxide radical inhibition assay 
The reaction mixture (6 mL) containing sodium 
nitroprusside (10 mM, 4 mL), phosphate buffer saline (1 
mL) and the extract or the standard (1 mL) was incubated 
at 25ºC for 150 min. After incubation, 0.5mL of the 
reaction mixture was removed and 1mL of sulphanilic acid 
reagent (0.33% in 20% glacial acetic acid) was mixed and 
allowed to stand for 5 min for completion of diazotization 
reaction and then 1mL of NEDD was added, mixed and 
allowed to stand for another 30 min in diffused light. The 
absorbance was measured at 540 nm against the 
corresponding blank solution in a 96-well microtitre plate 
(Tarsons Product (P) Ltd., Kolkata, India) using ELISA 
reader (Bio-Rad Laboratories Inc., Model 550)15, 16. 
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Scavenging of ABTS radical cation 
To 0.2 mL of the extract or standard, 1.0 mL of distilled 
DMSO and 0.16 mL of ABTS solution were added and 
incubated for 20 min. Absorbance of these solutions were 
measured spectrophotometrically at 734 nm17. 
Reducing power assay  
The extract (1mL) or the standard was added to 2.5 mL of 
1% potassium ferricyanide and the mixture incubated for 
20 minutes at 50ºC. Aliquots of trichloroacetic acid (2.5 
mL, 10%) was added to the mixture and centrifuged for 10 
minutes. The upper layer (2.5 mL) was mixed with 2.5 mL 
of water and 0.5 mL of 0.1% ferric chloride solution. 
Absorbance was measured at 700 nm against the 
corresponding blank solutions18. 
Scavenging of hydroxyl radical by p-NDA method 
The extracts or the standard in distilled DMSO (0.5 mL) 
was added to a solution mixture containing ferric chloride 
(0.1 mM, 0.5 mL), EDTA (0.1 mM, 0.5 mL), ascorbic acid 
(0.1 mM, 0.5 mL), hydrogen peroxide (2 mM, 0.5 mL) and 
p-NDA (0.01 mM, 0.5 mL) in phosphate buffer (pH 7.4, 
20 mM), to produce a final volume of 3 mL. Absorbance 
was measured at 440 nm19. 
Scavenging of hydrogen peroxide 
A solution of hydrogen peroxide (20 mM) was prepared in 
phosphate-buffered saline (PBS at pH 7.4). The extract / 
standard in methanol (1 mL) was added to 2mL of 
hydrogen peroxide solution in PBS. After 10 min the 
absorbance was measured at 230 nm20. 
In vivo antioxidant activity 
Animals were divided into six groups comprising of six 
animals in each group. Group I served as normal and 
received 1mL of 0.5% sodium carboxy methyl cellulose 
(CMC). Group II served as CCl4 treated control and 
received 1mL of 0.5% sodium CMC. Groups III received 
standard silymarin at 100 mg/kg body weight. Group IV, 
Groups V and VI received the successive chloroform 
extracts at 100, 200 and 400 mg/kg body weight, 
respectively. All these treatments were given orally for 7 
days. On day 8, except for group I, all the other groups 
received 1 mL/kg body weight of CCl4, intraperitoneally. 
On the day 9, the rats were anesthetized using diethyl ether 
and blood was collected from abdominal artery and kept at 
37ºC in the incubator for 30 min. Later, it was cold 
centrifuged at 2000 rpm for 15 min to get clear supernatant 
serum, which was used for biochemical estimations. Liver 
and kidneys were removed, weighed and homogenized 
immediately with Elvenjan homogenizer fitted with Teflon 
plunger, in ice-chilled 10% KCl solution (10 mg/g of 
tissue). The suspension was centrifuged at 2000 rpm at 4 
◦C for 10 min and the clear supernatant was used for 
biochemical estimations. Catalase was estimated by 
following the breakdown of hydrogen peroxide according 
to the method of beers et al.,
21
. Superoxide dismutase 
(SOD) was assayed based on the inhibition of epinephrine 
autooxidation by the enzyme22. Lipid peroxidation was 
measured in terms of malondialdehyde (MDA) content 
following the thiobarbituric acid method 23.  
Statistical analysis 
Results were expressed as mean ± S.E.M. Comparisons 
among the groups were tested by one-way ANOVA using 
Graph Pad Prism, Version 4.0 (Graph Pad Software, San 
Diego, CA, USA). When the p-value obtained from 
ANOVA was significant (p < 0.05), the Tukey test was 
applied to test for differences among groups. 
RESULTS 
Isolation of stigmasterol 
The melting point of isolated compound is 162ºC. IR 
bands (KBr): 3336, 2936, 2891, 1591, 1459, and 1051 
cm−1; FAB-MS:m/z 412 (M + 1). In the 1 H-NMR 
spectrum of the compound, the upfield region exhibited the 
presence of two tertiary methyls (δ 0.68 and 1.01), three 
secondary methyls (δ 0.98, 0.85 and 0.83) and a primary 
methyl (δ 0.85, overlapped with the secondary methyl 
group).  The olefinic protons were observed at δ 5.34 (1H, 
br.s), 5.16 (1H, dd) & 5.01 (1H,dd), suggesting the 
presence of two double bonds, while the carbinylic proton 
centered at δ 3.55 as a multiplet. 13C-NMR spectra showed 
recognizable signals at δ 14.60 (C-5), 138.26(C-23), 
121.65(C-22) and 121.63 (C-6)   confirming the presence 
of two double bonds. Among them the signal at δ 14.60 
(C-5) is of weak intensity, indicating that it is a quaternary 
atom.  The signal at δ 71.71 indicates the presence of the 
carbon atom under the hydroxyl function (C-3). These data 
confirm the structure of the compound as stigmasterol 
(Figure 1). 
 
Figure 1: Structure of Stigmasterol  
Total phenolic content estimation 
The total phenolic content of the four successive extracts 
were expressed as gallic acid equivalent in mg/g of 
extracts. Chloroform extract had the highest phenolic 
content, namely 29.2±0.8 mg/g, followed by ethyl acetate 
extract 16.5±0.2 mg/g. Ethyl acetate extract had the 
highest flavonoid content 4.7±0.1 mg/g followed by 
chloroform extract 19.2±0.15 mg/g. 
In vitro antioxidant assay 
The four successive extracts and the fraction ILCF-28 
were tested for in vitro antioxidant activity. The results are 
given in Table I. The data reveal that in the DPPH method 
potent antioxidant activity was observed for ILCF-28, ILC 
and ILE with IC50 value of 19.3 ± 0.91, 25.02 ± 0.05 and 
90.69 ± 0.72 g/ml, respectively. ILE and ILHM showed 
good to moderate antioxidant activity with IC50 value of 
120.20 ± 0.17 and 176.34 ± 0.61 g/ml, respectively. The 
successive n-hexane extract of Ipomoea leari ILH showed 
poor antioxidant activity. 
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Table 1: In vitro antioxidant activity of different extracts and fractions 
*
Average of three independent determinations, three replicates and values are mean ± SEM 
In the Nitric oxide method, potent antioxidant activity 
was observed for ILCF-28 with an IC50 value of 26.72 ± 
0.72 g/ml. ILC also showed potent antioxidant activity 
(but lower than both the standards) with an IC50 value of 
37.97 ± 2.11 g/ml. ILE showed good to moderate 
antioxidant activity with IC50 value of 117.12 ± 0.31 and 
165.21 ± 0.41 g/ml, respectively. ILH and ILHM show 
no or weak antioxidant activity.  
In ABTS method, ILCF-28 exhibited potent antioxidant 
activity with, IC50 value of 54.22 ± 1.12 g/ml. ILC also 
showed potent antioxidant activity with IC50 value of 
65.19 ± 0.21 g/ml. ILC, ILE showed moderate 
antioxidant activity with IC50 value of 287.03 ± 1.22 and 
310.57 ± 2.01 g/ml, respectively. ILP and ILHM 
showed weak activity even at the highest concentrations 
tested. 
In the reducing power method ILCF-28 exhibited good 
antioxidant activity with IC50 value of 125.15 ± 1.04 
g/ml. ILC and ILE, showed moderate antioxidant 
activity with IC50 value of 195.31 ± 2.01 and 362.56 ± 
0.02 g/ml, respectively. ILH showed no antioxidant 
activity. ILHM showed weak activity even at high 
concentrations tested. 
In the p-NDA method ILCF-28 exhibited moderate 
activity with IC50 value of 341.01 ± 0.32 g/ml. ILC and 
ILE showed weak activity with IC50 value of 402.01 ± 
0.22 and 589.21 ± 0.55 g/ml, respectively. ILHM 
showed weak activity even at high concentrations tested. 
In H2O2 method ILC-28 exhibited moderate activity with 
IC50 value of 480.21 ± 2.01 g/ml. The remaining 
extracts and fractions are inactive. 
In vivo antioxidant assay 
ILC and ILCF-28 has showed potent in vitro antioxidant 
activity compared to other extracts. ILC showed total 
phenolic content. Hence, ILC was selected for the in vivo 
antioxidant screening. The administration of ILC at 100, 
200 and 400 mg/kg bodyweight for 7 days prior to CCl4 
treatment caused a significant increase in the levels of 
catalase and SOD and a significant decrease in the levels 
of LPO in serum, liver and kidney. 
In vivo lipid peroxidation  
The localization of radical formation resulting in lipid 
peroxidation is measured as MDA in serum, liver and 
kidney. MDA content in the serum, liver and kidney 
significantly increased in CCl4 control group compared to 
the normal group (p<0.001).Pretreatment with ILC at all 
the three doses (100, 200 and 400 mg/kg), however, 
significantly inhibited the MDA level by 42.70, 50.88 and 
84.16%, respectively, for serum, 44.77, 61.29 and 83.04 
%, respectively for liver and 44.99, 59.24 and 74.25 %, 
respectively for kidney when compared to CCl4 control. 
The percentage inhibition for silymarin (100 mg/kg) on 
MDA levels was, however, 91.64, 89.52 and 85.71 %, for 
serum, liver and kidney, respectively. 
In vivo antioxidant enzymes 
The SOD levels of serum, liver and kidney in CCl4 
control group were significantly lower than in normal 
group (p<0.001). Pretreatment with ILC at the entire three 
dose levels (100, 200 and 400 mg/kg), however, 
significantly increased the SOD levels by 31.46, 55.94 
and 87.41 %, respectively for serum, 32.12, 55.15 and 
72.72 %, respectively for liver and 52.94, 66.01 and 79.73 
%, respectively for kidney when compared to CCl4 
control. The percentage increase for silymarin (100 
mg/kg) on SOD levels was, however, 93.70, 84.24 and 
86.92 %, for serum, liver and kidney, respectively. 
Catalase activity of CCl4 control group was seen to be 
strikingly lower than the normal group 
(p<0.001).Pretreatment with ILC at all the three dose 
levels (100, 200 and 400 mg/kg), however, significantly 
increased the catalase levels by 21.92, 69.79 and 88.19%, 
respectively for serum, 36.15, 59.50, 86.85 %, 
respectively for liver and 27.19, 56.61 and 72.09 %, 
respectively for kidney when compared to CCl4 control. 
The percentage increase for silymarin (100 mg/kg) on 
catalase levels was, however, 85.14, 87.78 and 74.32 %, 
for serum, liver and kidney, respectively. 
The analysis of the results  reveal, alterations in the 
activities of antioxidant enzymes (SOD and catalase), 
lipid peroxidation, serum, liver and kidney of CCl4 
intoxicated rats. Administration of ILC at 100, 200 and 
400 mg/kg for 7 days prior to CCl4 treatment showed 
significant protection. 
DISCUSSION 
CCl4 hepatotoxicity depends on the reductive 
dehalogenation of CCl4 catalysed by Cyt 450 in the liver 
cell endoplasmic reticulum leading to the generation of an 
unstable complex CCl3• radical. This trichloromethyl 
radical has been shown to be a highly reactive species, 
capable of attacking microsomal lipids leading to its 
peroxidation. This also covalently binds to microsomal 
lipids and proteins initiating secondary biochemical 
Sample IC 50 values ± SEM
* 
(µg/mL) 
DPPH Nitric oxide  ABTS Reducing 
power 
    p-NDA Hydrogen 
peroxide 
ILH  225.27±1.20 >1000 278.36±0.31 >1000 >1000 >1000 
ILC 
ILCF-28 
25.02±0.05 
19.31±0.91 
37.97±2.11 
26.72±0.72 
65.19±0.21 
54.22±1.12 
195.34±2.01 
125.15±1.04 
402.01±0.22 
341.01±0.32 
516.21±3.11 
480.21±2.01 
ILE 90.69±0.72 117.12±0.31 287.03±1.22 362.56±0.02 589.21±0.55 >100 
ILHM 176.34±0.61 187.43±1.32 353.87±2.10 416.77±1.22 >1000 790.31±2.11 
   Ascorbic Acids                       10.41±0.41 7.32±0.36 7.22±1.11 >1000 550 - 
Rutin 0.72±0.31 19.49±0.22 1.86±0.15 - 196.32±0.32 - 
BHA - - - - - 22.43±1.02 
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processes which is the ultimate cause for the unfolding of 
the panorama of pathological consequences of CCl4 
metabolism24. 
Further, oxidative stress, the consequence of an 
imbalance of pro oxidants and antioxidants in the 
organism, is also gaining recognition as a key 
phenomenon in chronic illnesses like inflammation, heart 
diseases, hypertension and some forms of cancer25. ROS 
produced through mechanism of signaling leads to 
deleterious effects. Hydrogen peroxide (ROS) has been 
reported as an important mediator of signaling oriented to 
the activation of transcription factors which are sensible 
to redox cycle and activators of responsible genes of 
cancerigenic cells growth and of some inflammatory 
processes. Oxidative stress results in toxicity when the 
rate at which the ROS are generated exceeds the cell 
capacity for their removal. Lipid peroxidation is an 
autocatalytic process, which is a common consequence of 
cell death. This process may cause peroxidative tissue 
damage in inflammation, cancer and toxicity of 
xenobiotics and aging. MDA is one of the end products in 
the lipid peroxidation process26.  
The data obtained in our present study (Table 2) clearly 
show an increase in the MDA level in serum, liver and 
kidney of rats treated with CCl4 suggesting enhanced 
lipid peroxidation leading to tissue damage and failure of 
antioxidant defense mechanisms to prevent formation of 
excessive free radicals. Treatment with ILC, however, is 
seen to significantly reverse these changes in a dose 
dependent manner. ILC at 400 mg/kg significantly (p < 
0.001) inhibited the formation of MDA levels in CCl4 
treated group and this is seen to be comparable with the 
standard drug silymarin. 
Biological systems protect themselves against the 
damaging effects of activated species by several means. 
These include free radical scavengers and chain reaction 
terminators; enzymes such as SOD and CAT system27. 
The SOD converts superoxide radicals (O2 −) into H2O2 
plus O2, thus participating with other antioxidant 
enzymes, in the enzymatic defense against oxygen 
toxicity. The data obtained in the present study (Table 2) 
reveals that there is an increase of SOD activity in a dose 
dependent manner suggesting that the ILC has an 
efficient protective effect in response to ROS. ILC at 400 
mg/kg and silymarin at 100 mg/kg significantly (p < 
0.001) restores the SOD activity in CCl4 treated groups.  
CAT is a key component of the antioxidant defense 
system. Inhibition of this protective mechanism results in 
enhanced sensitivity to free radical induced cellular 
damage. The reduction in the activity of CAT may, 
therefore, result in a number of deleterious effects due to 
the accumulation of superoxide radicals and hydrogen 
peroxide
28
. The data obtained in the present study reveals 
that administration of ILC increases the CAT level in 
CCl4 induced liver damage to rats thus preventing the 
accumulation of excessive free radicals and protects the 
liver from CCl4 intoxication. ILC at 400 mg/kg and 
silymarin at 100 mg/kg almost significantly (p < 0.001) 
restore the enzyme activity to the near normal levels.  
 During hepatic injury, superoxide radicals generate at the 
site of damage and modulate SOD and CAT, resulting in 
the loss of activity and accumulation of superoxide 
radical, which damages liver. Decreased CAT activity is 
linked to unexhaustion of the enzyme as a result of 
oxidative stress caused by CCl4. The reduced levels of 
SOD and CAT, in CCl4 treated rats, significantly 
increases when treated with plant extracts thus showing 
that antioxidant property of the extract29, 30. 
The phytochemical studies carried out on ILC reveal the 
presence of carbohydrates, flavonoids, glycosides, 
steroids and phenols etc. An analysis of the data given in 
Table 1 reveals that the observed in vitro antioxidant 
activity of four successive extracts of Ipomoea leari 
correlates with its phenolic content. A number of 
scientific reports indicate certain terpenoids, steroids and 
phenolic compounds such as tannins, coumarins and 
flavonoids have protective effects due to its antioxidant 
properties31, 32, 33, 34. 
In the present study successive chloroform extract, ILC 
shows the presence of stigmasterol as a major compound 
which has been shown well to moderate antioxidant 
activity in different in vitro models by earlier workers35. 
Stigmasterol thus contributes to antioxidant nature of 
ILC. In conclusion, the present study clearly reveals that 
ILC has potent in vitro free radicals scavenging effect in 
different in vitro models and exhibits a dose dependent 
antioxidant activity by inhibiting lipid peroxidation and 
enhancing antioxidant enzymes such as SOD and CAT 
level, in CCl4 intoxicated rat model. ILC is, therefore, a 
potential therapeutic, thus making it an excellent 
candidate for more detailed investigations.
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Table 2: Effect of ILC and silymarin on antioxidant enzymes and lipid peroxidation in rat with carbon tetrachloride–induced hepatotoxicity 
 
 
The data in the parenthesis indicate percent protection in individual biochemical parameters from their elevated values caused by CCl4. 
The % of protection is calculated as 100 X (values of CCl4 control -values of sample) / (values of CCl4 control - values of vehicle control) 
Results are Mean ± SEM (n = 6) * p<0.05, ** p<0.01, *** p<0.001, When compared with ccl4 treated control +++ p<0.001, When compared to normal group 
Treatment 
Dose 
(mg /kg 
body wt) 
Catalase 
(IU/min/mg of tissue) 
SOD 
(Unit/min/mg of tissue) 
LPO 
(n mole of MDA/mg of tissue) 
Serum Liver Kidney Serum Liver Kidney Serum Liver Kidney 
Normal 0.5 mL 
sod.CMC 
1.513      ± 
0.034 
3.698 
± 0.252 
1.865 
± 0.435 
0.298 
± 0.079 
0.301 
± 0.108 
0.311 
± 0.029 
3.672 
± 0.135 
3.942 
± 0.139 
3.385 
± 0.183 
Control (CCl4) 1 mL 0.692 ± 
0.031+++ 
1.431 ± 
0.062+++ 
0.790 ± 
0.075+++ 
0.155 ± 
0.018+++ 
0.136 ± 
0.013+++ 
0.158 ± 
0.056+++ 
5.983 
± 0.620+++ 
8.306 
± 0.450+++ 
6.143 
± 0.238+++ 
Silymarin+CCl4 100 1.392 
± 0.052*** 
(85.14) 
3.421 
± 0.172*** 
(87.78) 
1.589 
± 0.089*** 
(74.32) 
0.289 
± 0.028*** 
(93.70) 
0.275 
± 0.013*** 
(84.24) 
0.291 
± 0.011*** 
(86.92) 
3.865 
± 0.111*** 
(91.64) 
4.399 
± 0.345*** 
(89.52) 
3.779 
± 0.154*** 
(85.71) 
ILC +  CCl4 100 0.872 
± 0.039 
(21.92) 
2.533 
± 0.164* 
(49.49) 
1.058 
± 0.069 
(24.93) 
0.298 
± 0.009* 
(31.46) 
0.189 
± 0.013 
(32.12) 
0.239 
± 0.041** 
(52.94) 
4.996 
± 0.270 
(42.70) 
6.354 
± 0.166** 
(44.77) 
4.902 
± 0.154** 
(44.99) 
ILC +  CCl4 200 1.265 
± 0.039*** 
(69.79) 
2.891 
± 0.132*** 
(64.40) 
1.389 
± 0.094*** 
(55.72) 
0.235 
± 0.006*** 
(55.94) 
0.227 
± 0.025*** 
(55.15) 
0.259 
± 0.039*** 
(66.01) 
4.807 
± 0.136** 
(50.88) 
5.631 
± 0.149*** 
(61.29) 
4.509 
± 0.152*** 
(59.24) 
ILC +  CCl4 400 1.375 
± 0.068*** 
(83.19) 
3.202 
± 0.153*** 
(78.12) 
1.565 
± 0.147*** 
(72.09) 
0.275 
± 0.014*** 
(87.41) 
0.256 
± 0.008*** 
(72.72) 
0.280 
± 0.006*** 
(79.73) 
4.038 
± 0.188*** 
(84.16) 
4.682 
± 0.191*** 
(83.04) 
4.101 
± 0.143*** 
(74.03) 
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